Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies

NCT04470947 · clinicaltrials.gov ↗

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Advanced Lymphoma
Refractory Lymphoma
Refractory Leukemia
Refractory Acute Myeloid Leukemia
Refractory T-Cell Lymphoma

Interventions

DIAGNOSTIC_TEST: Next generation functional drug screening
DIAGNOSTIC_TEST: Comprehensive genomic profiling

Sponsor

Medical University of Vienna

Collaborators

[object Object]
[object Object]